Advertisement
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Advertisement
No AccessJournal of UrologyPediatric Urology1 Jul 2013

Antibiotic Resistance Patterns of Outpatient Pediatric Urinary Tract Infections

    View All Author Information

    Purpose:

    We characterize the current national patterns of antibiotic resistance of outpatient pediatric urinary tract infection.

    Materials and Methods:

    We examined outpatient urinary isolates from patients younger than 18 years in 2009 using The Surveillance Network®, a database with antibiotic susceptibility results and patient demographic data from 195 United States hospitals. We determined the prevalence and antibiotic resistance patterns for the 6 most common uropathogens, ie Escherichia coli, Proteus mirabilis, Klebsiella, Enterobacter, Pseudomonas aeruginosa and Enterococcus. We compared differences in uropathogen prevalence between males and females using chi-square analysis.

    Results:

    We identified 25,418 outpatient urinary isolates. E. coli was the most common uropathogen overall but the prevalence of E. coli was higher among females (83%) than males (50%, p <0.001). Other common species among males were Enterococcus (17%), P. mirabilis (11%) and Klebsiella (10%). However, these uropathogens each accounted for 5% or less of female isolates (p <0.001). Resistance among E. coli was highest for trimethoprim-sulfamethoxazole (24%) but lower for nitrofurantoin (less than 1%) and cephalothin (15%). Compared to 2002 Surveillance Network data, E. coli resistance rates increased for trimethoprim-sulfamethoxazole (from 23% to 31% in males and from 20% to 23% in females) and ciprofloxacin (from 1% to 10% and from 0.6% to 4%, respectively).

    Conclusions:

    E. coli remains the most common pediatric uropathogen. Although widely used, trimethoprim-sulfamethoxazole is a poor empirical choice for pediatric urinary tract infections in many areas due to high resistance rates. First-generation cephalosporins and nitrofurantoin are appropriate narrow-spectrum alternatives given their low resistance rates. Local antibiograms should be used to assist with empirical urinary tract infection treatment.

    References

    • 1 : Urologic Diseases in North America Project: trends in resource utilization for urinary tract infections in children. J Urol2005; 173: 949. LinkGoogle Scholar
    • 2 : National ambulatory antibiotic prescribing patterns for pediatric urinary tract infection, 1998–2007. Pediatrics2011; 127: 1027. Google Scholar
    • 3 : A cost-effectiveness analysis of treatment strategies for acute uncomplicated pyelonephritis in women. Acad Emerg Med2003; 10: 309. Google Scholar
    • 4 : Multidrug resistance in pediatric urinary tract infections. Microb Drug Resist2006; 12: 126. Google Scholar
    • 5 : M100-S23—Performance Standards for Antimicrobial Susceptibility Testing; twenty-third informational supplement. Wayne, Pennsylvania: CLSI2013. Google Scholar
    • 6 : Another look at differences in the susceptibility of Escherichia coli and Klebsiella pneumoniae to cephalothin and cefazolin. Int J Antimicrob Agents2001; 17: 521. Google Scholar
    • 7 : Disk susceptibility studies with cefazolin and cephalothin. Antimicrob Agents Chemother1974; 5: 63. Google Scholar
    • 8 : Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J2008; 27: 302. Google Scholar
    • 9 : Antibiotic resistance patterns in children hospitalized for urinary tract infections. Arch Pediatr Adolesc Med2005; 159: 924. Google Scholar
    • 10 : Antibiotic resistance trends in paediatric uropathogens. Int J Antimicrob Agents2005; 26: 267. Google Scholar
    • 11 : International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis2011; 52: e103. Crossref, MedlineGoogle Scholar
    • 12 : Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship. Clin Infect Dis2007; 44: 159. Google Scholar
    • 13 : Closing the quality gap: a critical analysis of quality improvement strategies (vol. 4: Antibiotic prescribing behavior). Report No. 04(06)-0051-4 AHRQ Technical Reviews2006; . Google Scholar
    • 14 : National trends in emergency department antibiotic prescribing for elders with urinary tract infection, 1996–2005. Acad Emerg Med2009; 16: 500. Google Scholar
    • 15 : The ECO*SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens—interim report. J Antimicrob Chemother2000; 46: 15. Google Scholar
    • 16 : Risk factors for resistance to “first-line” antimicrobials among urinary tract isolates of Escherichia coli in children. CMAJ1999; 160: 1436. Google Scholar
    • 17 : Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. Eur J Clin Microbiol Infect Dis2007; 26: 83. Google Scholar
    • 18 : Usefulness of antibiogram surveillance for methicillin-resistant Staphylococcus aureus in outpatient pediatric populations. Diagn Microbiol Infect Dis2009; 64: 70. Google Scholar
    • 19 : Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data?. Diagn Microbiol Infect Dis2004; 49: 141. Google Scholar
    • 20 : Clinical value of an ambulatory-based antibiogram for uropathogens in children. J Pediatric Infect Dis Soc2012; 1: 333. Google Scholar